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ABSTRACT 
This study reported an improved method of trisaccharide (GlcNAcβ1, 3Galβ1, 4Glc) 
synthesis by fermentation of recombinant Escherichia Coli. The first part was designed for an 
induction temperature study. We want to compare the level of enzyme activity at different 
temperature and select the best condition to repeat the induction temperature in a fermenter to 
improve the production yield. First, the trisaccharide was synthesized at different induction 
temperature by direct fermentation (4L flask) of E. coli JM109 (DE3) harboring the LgtA-
pET22b plasmid. The bacterial growth and trisaccharide production were compared. Second, the 
best condition for bacterial growth and induction of recombinant enzyme expression was 
repeated in a fermenter to improve its production yield. After simple two-step purification, final 
products were obtained with purity above 90% and all products were characterized by MALDI-
TOF and HPLC. 
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1 INTRODUCTION 
Recent studies have shown that human milk oligosaccharides (HMOs) are a unique and 
irreplaceable component found in human breast milk. HMOs are a mixture of indigestible 
oligosaccharides composed of glucose, galactose, fucose, sialic acid and N-acetyl-glucosamine[1, 
2]. It’s essential to understand HMOs because it’s natural exist in the human body and more 
importantly, HMOs have several positive factors for the development of infants. For example, 
the human milk has more beneficial oligosaccharides than other milk sources, which supports 
infant’s immune system, and encourages the growth of beneficial bacteria in infant’s digestive 
system[3, 4]. Furthermore, some manufactured fucosylated HMOs are already available on the 
market, such as, 2-fucosyllactose (2-FL, Fucα1-2Galβ1-4Glc) and are added as supplement in 
infant formula such as Similac. The other fucosylated HMOs showed potential value in 
pharmaceuticals. Recent publications reported that lacto-N-fucopentaose III (LNFP III, Galβ1-
4(Fucα1-3) GlcNAcβ1-3Galβ1-4Glc) could reduce central nervous system inflammation and 
experimental allergic encephalomyelitis severity[5, 6]. Therefore, based on above potentials and 
benefits of HMOs, the approach for large-scale synthesis of HMO is highly demanded[7, 8]. 
From previous reports and publications, there are three strategies for oligosaccharide 
synthesis in large-scale production. (1) Enzymatic synthesis, (2) chemical synthesis, and (3) 
whole-cell synthesis or living cell factory[ 9 , 10 ]. All three strategies have their advantages, 
however, for synthesis of more complex oligosaccharides, chemical synthesis and enzymatic 
synthesis are still facing some weaknesses[11, 12]. 
Chemical synthesis of simple carbohydrates, such as 2-fucosyllactose (2-FL, Fucα1-2Galβ1-
4Glc) have been reported and achieved in large scale. However, for more complex structures, 
multistep of protection, deprotection processes, and relatively low production yield could affect 
the variable cost and efficiency of chemical synthesis[ 13 , 14 ]. On the other hand, enzymatic 
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synthesis was used as a suitable option because of its high stereoselectivity, high efficiency and 
under mild conditions, but the complex structure of oligosaccharidse will be limited by enzyme 
sources, and fussy enzyme purification processes[15, 16]. 
According to the third strategy, using whole-cell synthesis or living cell factory, a Japanese 
company Kyowa Hakko Kogyo Co has achieved a 100 gram-scale oligosaccharide production by 
using cheap stating materials and engineered bacteria for the production of oligosaccharides[17, 
18 ]. Similarly, our group achieved trisaccharide(GlcNAcβ1-3Galβ1-4Glc) synthesis by using 
“superbug technology”, which contained recombinant enzyme expression in Escherichia Coli. 
Even so, both Kyowa Hakko Kogyo’s method and superbug technology were still limited on 
complex oligosaccharide production and could not synthesize functional HMOs in only one 
batch. Based on current challenges we noticed that changing enzymatic reaction conditions and 
take advantages of a fermenter could improve the production of the HMOs staring structure, 
trisaccharide(GlcNAcβ1-3Galβ1-4Glc)[ 19 , 20 ]. As presented in Figure 1, the trisaccharide 
synthesis start with lactose, and an engineered E. coli expressing a β1–3-N-
acetylglucosaminyltransferase from Neisseria meningitidis (NmLgtA or LgtA) for the enzymatic 
reaction of trisaccharide(GlcNAcβ1-3Galβ1-4Glc) synthesis. In this study, HMOs starting 
structure were successfully synthesized in engineered E. coli at the studied induction 
temperature, and the best condition was repeated in a fermenter to achieve an improved result. 
Lastly, the product was purified by two simple step purifications and characterized by MALDI-
TOF-MS (Matrix-Assisted Laser Desorption/Ionization Time of Flight Mass Spectrometry) and 
HPLC-ELSD (High Performance Liquid Chromatography-Evaporative Light Scattering 
Detector)[21, 22]. 
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Figure 1.  A trisaccharide synthesis process by “super bug” technology. 
1.1 Purpose of the Study  
Overall, the purpose of this study is to synthesize a large amount of trisaccharide using the 
best condition and easiest method. First, the best induction temperature was selected for 4L flask 
reaction. Second, repeat the selected induction temperature in a fermenter to prove the utility of 
this method, and use minimal medium to increase production yield and efficiency. Third, use 
two-step purification to purify the product and ended with purity above 90%. 
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Materials and Methods 
1.2 Microorganism and materials 
Engineered E. coli strain JM109 (DE3) and LgtA-pET22b plasmid were prepared and 
stored at Dr. Peng Wang’s lab. Bio-Gel P2 Gel (fine) was from Bio-Rad Laboratories. Activated 
charcoal and other reagents were from Sigma. 
1.3 Media and solutions 
LB (Luria-Bertani) medium and minimal medium were used in this experiment. LB 
medium and minimal medium were used for preparation of the seed culture of E. coli strain 
JM109 (DE3). LB medium was used as seed medium and flask medium, and minimal medium 
was used as fermenter medium and fed medium which contained (KH2PO4 7.8 g/L, Citric acid 1 
g/L, (NH4)2SO4, 2.33 g/L, Trace metal solution 1 ml/L, Glycerol 22 g/L, MgSO4 1 g/L, CaCl2 40 
mg/L, Ampicillin 100 mg/L)[23, 24]. 
1.4 Experimental method 
1.4.1 Enzyme expression of LgtA 
For growth of E. coli harboring LgtA-pET22b, use one 125 ml flask, and two 4-L flasks, 
wash them very carefully. Weight 1.25g LB medium in the 125-ml flask, fill up with 50 ml 
water. Weight 50g LB medium in the 4-L flask, and fill up with 2L water. Carefully seal the 
flasks with aluminum wraps and tape sterilization indicator on each flask; send them to high-
pressure steam sterilization pot and make sure the indicator turned black after sterilization. 
After sterilization, cool down to room temperature and add 5ul of the seed E. coli and 50 
ul (100 mg/ml) antibiotic to 125 ml flask under bacteria-free environment. Transfer the 125ml 
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flask to 37ºC shaker and incubate overnight. After 24h transfer all the culture from 125 ml flask 
and evenly distribute to two 4-L flasks, add 2ml antibiotic under bacteria-free environment. 
Shake well and place the 4-L flasks in 37ºC shaker and incubate for 3h. After 3h, the liquid 
turned from clear to cloudy, place both flask at room temperature and let it cool down to room 
temperature. At this stage, the growth of E. coli in 4-L flasks reaches the OD600nm range of 0.6-
0.8. Table 1 and Figure 2 summarized the growth rate of E. coli in LB medium. 
Table 1 Enzyme growing table 
Time Flask 1 Flask 2 
1h 0.063 0.070 
3h 0.281 0.322 
4h 0.624 0.671 
 
 
Figure 1. E. coli growth chart 
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1.4.2 Enzymatic synthesis of trisaccharide (GlcNAcβ1-3Galβ1-4Glc) 
At this step, enzymatic synthesis of trisaccharide is ready to proceed, more importantly, 
besides using the enzymatic reaction at 16 ºC (the condition used from previous studies) we also 
want to do a temperature comparison study at three different temperatures 16ºC, 20 ºC and 24 ºC 
to explore at what temperature the growth of bacteria is highest, but without losing enzyme 
activity after expression is induced. Prepare three sets of 4-L flasks (2 flasks per set) that 
contained the bacteria culture (OD600nm 0.6-0.8). Add 30g prepared lactose solution and 
isopropyl β-D-1-thiogalactopyranoside (IPTG) into each flask under bacteria free environment. 
Transfer all three sets flasks to three shakers with temperature at 16ºC, 20 ºC and 24 ºC, 
respectively. Shake overnight and collect flasks. Table 2 and Figure 2 summarized OD600 
values of E. coli at different induction temperatures. 
 
Table 2 OD600 values of E. coli culture at different induction temperatures 
     Induction Temperature oC Culture 3h at 37°C Induction 22h 
16 0.864 1.791 
20 0.791 1.915 
24 0.687 1.985 
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Figure 2. OD600 values of E. coli culture at different induction temperatures 
1.4.3 Repeated Enzymatic Synthesis of trisaccharide (GlcNAcβ1-3Galβ1-4Glc) in a Fermentation 
First, 1.25 g minimal medium was weighted and transferred to a 125-ml flask, fill the flask 
with 50 ml water. Carefully seal the flask with aluminum wraps and sterilize using a high-
pressure steam sterilization pot. After sterilization, cool the flask to room temperature. When it 
reached room temperature, add 5ul of the seed E. coli and 50 ul of antibiotic to the 125-ml flask 
under bacteria-free environment. Transfer the 125ml flask to 37ºC 180 rpm shaker and shake 
overnight[25, 26]. 
Carefully disconnect tubes and capes from the fermentation cylinder, wash the cylinder and 
other necessary flasks with ddH2O. Dry the cylinder and pour prepared minimal medium into the 
cylinder and flasks. Lastly, adjust pH of the buffer solution and close all lids and wrap all the 
connections with aluminum and send to an autoclave. After sterilization, start the system and 
stirring the medium until pH level and temperature stabilized (usually take one day). Next 
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transfer 50ml E. coli culture into the cylinder and keep stirring at 37ºC overnight, after stirring 
overnight, add prepared lactose solution and isopropyl β-D-1-thiogalactopyranoside (IPTG) into 
the cylinder and change the temperature control to 24 ºC. Results are shown in Table 3 and 
Figure 4. 
Table 3 OD600 values of E. coli culture in the fermenter 
E. coli growth time (h) OD600 
0 0.063 
2 0.100 
3.5 0.243 
20 5.00 
22 16.82 (add IPGT to start induction) 
23.5 23.29 
43.5 30.64 
46 30.95 
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Figure 3 OD600 values of E. coli culture in the fermenter 
 
1.4.4 Trisaccharide (GlcNAcβ1-3Galβ1-4Glc) purification and analysis 
Our trisaccharide purification process has two steps. The first step is purification using 
activated charcoal (Figure 4). First, collect the cells from 2-L medium and transfer all the liquids 
to 2-L centrifuge bottles, centrifuge at 4,000 rpm for 30min. After centrifugation, collect 
supernatant and save the sample for analysis. Collect the pellet and dilute with 25 ml ddH2O into 
50ml centrifuge tube and boil the tube in boiling water for 20min, then centrifuge again at 7,000 
rpm for 30 mins and collect supernatant in 50 ml tube. 
Next weigh 40g charcoal and 20g silica gel, mix them well and pack into a column 
(Biotage SNAP Cartridge KP-Sil 100g). Activate the charcoal column with 800ml methanol and 
wash with 600ml ddH2O, then load samples on the surface of charcoal and wait until the sample 
absorbed into charcoals. Wash with 600ml ddH2O again and 600ml 5% ethanol. Lastly, elute 
with 800ml 50% ethanol and collect the eluted sample[27, 28]. 
 
Figure 4 trisaccharide (GlcNAcβ1-3Galβ1-4Glc) purification step 1 
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Collect the 800ml compound and concentrate to about 3ml, then rinse with 2ml water and 
make sure that the total volume is less than 5ml. The next step is P2 column purification (P2 is a 
size exclusion purification method). Before loading samples, make sure the P2 column is washed 
and rinsed overnight through water. When loading, carefully load sample on the surface of the 
P2 gel and wait until the liquid fully loaded into the gel, and fill up with water and let samples 
run through the entire column and collect the fractions.  Figure 5 illustrates the principle of P2 
column in the purification process[29]. 
 
Figure 5 Final purification step 
 
2 RESULTS AND DISCUSSION  
Without purification, when running through the HPLC the peak for trisaccharide produced 
from the cytosol of E. coli grown at all three induction temperatures was found at 20min. By 
comparing the peak area, the induction temperature at 24ºC gave the highest trisaccharide 
concentration (Figure 6).  
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Figure 6 HPLC result of trisaccharide (GlcNAcβ1-3Galβ1-4Glc) (cytosol) 
However, the HPLC result from medium alone showed a very low concentration of 
trisaccharide (Figure 7). Therefore, the most enzymatic reaction of trisaccharide synthesis was 
happening in the cytosol and the trisaccharide remained in the cytosol. 
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Figure 7 HPLC result of trisaccharide (GlcNAcβ1-3Galβ1-4Glc) (in medium) 
After the simple two steps purification, the product from all three induction temperatures 
in 4L flasks and the 2L fermenter was also identified at 20mins (Figure 8).  
 
Figure 8 HPLC result of purified trisaccharide (GlcNAcβ1-3Galβ1-4Glc) 
 
13 
The trisaccharide synthesized from flasks and the fermenter is confirmed by MALDI-
TOP (Figure 9) 
 
Figure 9 MALDI-TOP result of purified trisaccharide (GlcNAcβ1-3Galβ1-4Glc) 
After the two step purification, trisaccharide from flasks and fermenter reached purity 
above 90% (Table 4).  
 
Table 4 Final product purity 
 Induction Temperature Area Total area Purity (%) 
4L Flask 16 895129 979645 91.37 
4L Flask 24 592995 628997 94.28 
2L Fermenter 24 460403 495686 92.88 
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Figure 10 Final production yield from 4L flasks 
 
Based on the yield of crude product, there are about 50% lost after initial purification, 
about less than 30% lost after final purification (Figure 10). However, because the purification 
method and its efficiency were not suitable for multi-gram scale synthesis of oligosaccharides, 
therefore, the final production yield from 2L fermenter was estimated by comparing to the 4L 
flask production/purification yield (Figure 11).   
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Figure 11 Estimated yield from 2L fermenter  
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3 CONCLUSIONS 
From this study, superbug technology was used to successfully synthesize trisaccharide 
(GlcNAcβ1-3Galβ1-4Glc) at three different induction temperatures, 16ºC, 20ºC, and 24ºC. The 
purity of the purified products from E. coli grown at the three temperatures is all above 90%. 
However, the percentage yield of trisaccharide (GlcNAcβ1-3Galβ1-4Glc) at 24ºC showed a 
limited success than the other two induction temperatures. After repeating this method at 24ºC 
induction temperature in a 2-L fermenter, the production yield and the experimental efficiency 
has improved. As a result, 24ºC induction temperature using a fermenter is an improved method 
for the synthesis of HMO staring structure (trisaccharide (GlcNAcβ1-3Galβ1-4Glc)). By using 
this improved method using a fermenter, the cost of HMOs’ production may be decreased and 
the demand of HMOs’ study and applications in relating areas may increase.  
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